Great Lakes Discovery, the collaboration between Deerfield Management and the University of Michigan, will help facilitate Dr. David Markovitz M.D.’s lab to pursue a therapeutic treatment for systemic inflammation through the new exploratory biologics initiative.  David Markovitz is a Professor of Internal Medicine in the Division of Infectious Diseases who also has appointments in the programs in Cellular and Molecular Biology, Cancer Biology, and Immunology. This is the first project in the Great Lakes Discovery pipeline as well as the exploratory biologics initiative. 

U-M and Deerfield on Wednesday announced the launch of Great Lakes Discovery LLC. Deerfield has committed up to $130 million over the next decade to invest in biomedical research at U-M with the aim of developing potentially life-saving drugs and disease treatments.